Brooks O'Neil
Stock Analyst at Lake Street
(1.15)
# 3,731
Out of 4,984 analysts
36
Total ratings
35.29%
Success rate
-10.49%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $12.43 | -3.46% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $6.25 | +28.00% | 7 | Aug 11, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $14 | $6.01 | +132.95% | 3 | Aug 6, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $8.38 | +138.66% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $31.91 | +34.75% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $92.45 | +18.98% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $23.29 | +28.81% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $29.11 | +143.90% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $10.71 | +142.76% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $42.89 | +28.25% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $15.03 | +19.76% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.86 | +2.88% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.97 | +72.17% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $24.39 | +6.60% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.70 | +1,472.33% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $34.10 | +273.90% | 1 | Sep 15, 2020 |
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $12.43
Upside: -3.46%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $6.25
Upside: +28.00%
LifeMD
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $14
Current: $6.01
Upside: +132.95%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $8.38
Upside: +138.66%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $31.91
Upside: +34.75%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $92.45
Upside: +18.98%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $23.29
Upside: +28.81%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $29.11
Upside: +143.90%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $10.71
Upside: +142.76%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $42.89
Upside: +28.25%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $15.03
Upside: +19.76%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.86
Upside: +2.88%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.97
Upside: +72.17%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $24.39
Upside: +6.60%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.70
Upside: +1,472.33%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $34.10
Upside: +273.90%